Introduction - Several 11C-tracers
have demonstrated high potential in early diagnostic PET imaging applications
of neurodegenerative diseases including Alzheimer’s and Parkinson’s
disease. These radiotracers often track critical biomarkers in disease
pathogenesis such as tau fibrils ([11C]PBB3) or β-amyloid
plaques ([11C]PiB) associated with such diseases. Purpose - The short review aims to serve as a guideline
in the future development of radiotracers for students, postdocs and/or
new radiochemists who will be synthesizing clinical grade or novel
research 11C-tracers, including knowledge of regulatory
requirements. We aim to bridge the gap between novel and established 11C-tracer quality control (QC) processes through exploring
the design process and regulatory requirements for 11C-pharmaceuticals. Methods - A literature survey was undertaken to identify
articles with a detailed description of the QC methodology and characterization
for each of the sections of the review. Overview -
First a general summary of 11C-tracer production was presented;
this was used to establish possible places for contamination or assurances
for a sterile final product. The key mandated QC analyses for clinical
use were then discussed. Further, we assessed the QC methods used
for established 11C-tracers and then reviewed the routine
QC tests for preclinical translational and validation studies. Therefore,
both mandated QC methods for clinical and preclinical animal studies
were reviewed. Last, some examples of optimization and automation
were reviewed, and implications of the QC practices associated with
such procedures were considered. Conclusion - All
of the common QC parameters associated with 11C-tracers
under clinical and preclinical settings (along with a few exceptions)
were discussed in detail. While it is important to establish standard,
peer-reviewed QC testing protocols for a novel 11C-tracer
entering the clinical umbrella, equal importance is needed on preclinical
applications to address credibility and repeatability for the study.